NEW YORK (Reuters Health) – In terms of quality of life for patients with COPD, the improvements in lung function and exacerbation frequency produced by phosphodiesterase 4 (PDE4)…
NEW YORK (Reuters Health) – Compared with the standard long protocol using gonadotrophin-releasing hormone (GnRH) agonists during ovarian stimulation, the use of GnRH antagonists results in comparable live-birth…
NEW YORK (Reuters Health) – Although serum zinc concentration increases in response to intake of a liquid zinc supplement in Senegalese children, this is not the case with…
NEW YORK (Reuters Health) – Among patients seen in the emergency department with chest pain, cardiac CT findings predict their risk for major adverse cardiac events (MACE) in…
NEW YORK (Reuters Health) – There’s now one more reason for statin loading before percutaneous coronary intervention. As well as reducing myocardial damage, high-dose atorvastatin given shortly before…
NEW YORK (Reuters Health) – Clonidine in the form of extended-release tablets improves response to psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder, results of a phase…
NEW YORK (Reuters Health) – Many patients with acute MI have risk factors for shock, which increase the likelihood of adverse outcomes with early initiation of beta-blocker therapy,…
NEW YORK (Reuters Health) – Ventricular pauses associated with the use of ticagrelor don’t result in clinically significant bradycardia, according to a report in the May 10th Journal…
NEW YORK (Reuters Health) – Roughly one-third of venous thromboembolism (VTE) events that occur in patients who’ve had surgery for cancer happen after they leave the hospital, with…
NEW YORK (Reuters Health) – Older people with chronic obstructive pulmonary disease may live longer if started on an inhaled long-acting beta-agonist than an inhaled long-acting anticholinergic, Canadian…